Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
Be(2)-c |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
Be(2)-c |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
Be(2)-c |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
Be(2)-c |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
Be(2)-c |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
IMR-32 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
IMR-32 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
IMR-32 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
IMR-32 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
IMR-32 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
LAN-5 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
LAN-5 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
LAN-5 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
LAN-5 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
LAN-5 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
0.62 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
1.25 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
2.50 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
5.00 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
Staining with TOTO-3 Iodide |
Influence on cell viability |
10.00 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
Be(2)-c |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
Be(2)-c |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
Be(2)-c |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
Be(2)-c |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SMS-KCNR |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SMS-KCNR |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SMS-KCNR |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
IMR-32 |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
IMR-32 |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
IMR-32 |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
IMR-32 |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
LAN-5 |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
LAN-5 |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
LAN-5 |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity |
5.00 µM |
LAN-5 |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
MM1.RL |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
MM1.RL |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
MM1.RL |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
U266 |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
U266 |
Homo sapiens |
|
p-STAT3 (S727) |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
U266 |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
10.00 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
5.00 µM |
MM1.RL |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
5.00 µM |
MM1.RL |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
5.00 µM |
MM1.RL |
Homo sapiens |
|
|
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
5.00 µM |
U266 |
Homo sapiens |
|
p-STAT3 (Y705) |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
5.00 µM |
U266 |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Western Blot |
Influence on protein activity in presence of IL-6 |
5.00 µM |
U266 |
Homo sapiens |
|
|
|
Withaferin A |
MTT |
Influence on cell viability |
N/A µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
MTT |
Influence on cell proliferation |
1.00 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Wound healing assay |
Influence on cells motility |
0.00 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Wound healing assay |
Influence on cells motility |
0.01 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Wound healing assay |
Influence on cells motility |
0.10 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Wound healing assay |
Influence on cells motility |
1.00 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Transwell migration assay |
Influence on cells motility |
1.00 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Transcriptional activity assay |
Influence on protein transcriptional activity in presence of IL-6 |
0.06 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Transcriptional activity assay |
Influence on protein transcriptional activity in presence of IL-6 |
0.12 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Transcriptional activity assay |
Influence on protein transcriptional activity in presence of IL-6 |
0.25 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Transcriptional activity assay |
Influence on protein transcriptional activity in presence of IL-6 |
0.50 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Transcriptional activity assay |
Influence on protein transcriptional activity in presence of IL-6 |
1.00 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Immunofluorescence |
Influence on protein transcriptional activity in presence of IL-6 |
1.00 µM |
HCT116 |
Homo sapiens |
|
STAT3 |
|
Withaferin A |
Immunofluorescence |
Influence on protein transcriptional activity in presence of IL-6 |
1.00 µM |
HCT116 |
Homo sapiens |
|
|
|
Withaferin A |
Tumor weight |
Influence on tumor growth |
2.00 mg/kg |
HCT116 (xenograft) |
Mus musculus |
BALB/c |
|
|
Withaferin A |
Tumor volume |
Influence on tumor growth |
2.00 mg/kg |
HCT116 (xenograft) |
Mus musculus |
BALB/c |
|
|
Withaferin A |
Body weight |
Influence on tumor growth |
2.00 mg/kg |
HCT116 (xenograft) |
Mus musculus |
BALB/c |
|
|